Luca Benatti

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Brendan Hannah as attorney-in-fact for Luca Benatti
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Luca Benatti:

Company Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Director Common Stock 39,179 $135,951 $3.47 26 Dec 2025 Direct
Quince Therapeutics, Inc. Director Director Stock Option (Right to Buy) 27,000 04 Jun 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct

Insider Reports Filed by Luca Benatti

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QNCX Quince Therapeutics, Inc. 26 Dec 2025 1 -$173,500 4 Director 29 Dec 2025, 17:36
QNCX Quince Therapeutics, Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:38
QNCX Quince Therapeutics, Inc. 23 Oct 2024 1 $0 4 Director 29 Dec 2025, 17:34
QNCX Quince Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 20:57
/report/000110465923117110-benatti-luca-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 12 -$638,362 4 Director 13 Nov 2023, 14:46
QNCX Quince Therapeutics, Inc. 23 Oct 2023 1 $0 4 Director 24 Oct 2023, 19:46
QNCX Quince Therapeutics, Inc. 23 Oct 2023 0 $0 3 Director 24 Oct 2023, 19:43
/report/000110465923064846-benatti-luca-2023-05-24 INTERCEPT PHARMACEUTICALS, INC. 24 May 2023 2 $0 4 Director 25 May 2023, 20:40
/report/000110465922065918-benatti-luca-2022-05-25 INTERCEPT PHARMACEUTICALS, INC. 25 May 2022 2 $0 4 Director 27 May 2022, 16:18
/report/000110465921075215-benatti-luca-2021-05-27 INTERCEPT PHARMACEUTICALS, INC. 27 May 2021 2 $0 4 Director 01 Jun 2021, 19:00